Covid-19 Updates | Cancer Biomarkers Market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions

Read More: https://www.rootsanalysis.com/....reports/view_documen

Favicon 
www.rootsanalysis.com

Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing | Industry Analysis | Market Size | 2030

The Novel Immuno-Oncology / Cancer Biomarker Testing market is anticipated to grow at an annualized rate of ~18% over the next decade